JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

JHS Svendgaard Laboratories Ltd has touched a new 52-week low of Rs.8.55 today, marking a significant decline in its stock price amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

JHS Svendgaard Laboratories Ltd has touched a fresh 52-week low of Rs.8.95 today, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial metrics and market sentiment.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 November 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

JHS Svendgaard Laboratories Ltd., a micro-cap oral care products manufacturer, reported a net loss of ₹0.20 crores in Q2 FY26 (Jul-Sep'25), reversing from a profit of ₹1.06 crores in the previous quarter. The company's stock, currently trading at ₹10.80, has declined 2.96% following the results announcement and remains down 40.46% over the past year, significantly underperforming the FMCG sector's 4.92% gain. With a market capitalisation of just ₹99.00 crores and a troubling financial track record, the Himachal Pradesh-based manufacturer faces mounting challenges in restoring investor confidence.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 November 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 November 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with an up-to-date view of the company's performance and outlook.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 19 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

JHS Svendgaard Laboratories Ltd, a player in the FMCG sector, recorded a new 52-week low of Rs.8.97 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges.

JHS Svendgaard Laboratories Ltd has touched a fresh 52-week low of Rs.9.04 today, marking a significant decline in its share price amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about its financial health and market positioning.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 06 January 2026, providing investors with the latest insights into its performance and prospects.

JHS Svendgaard Laboratories Ltd’s stock declined to a fresh 52-week low of Rs.9.17 today, marking a significant downturn amid continued underperformance relative to its sector and benchmark indices.

JHS Svendgaard Laboratories Ltd’s stock declined to a fresh 52-week low of Rs.9.36 today, marking a significant downturn amid ongoing pressures in the FMCG sector. Despite outperforming its sector peers by 3.42% on the day, the stock remains substantially below its previous highs and continues to reflect underlying financial and market challenges.

JHS Svendgaard Laboratories Ltd has declined to a fresh 52-week low, closing near Rs 9.52, marking a significant downturn in the stock’s performance over the past year. This new low reflects ongoing challenges faced by the company within the FMCG sector, as it continues to underperform against key benchmarks and sector averages.

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.